Biotech Press Releases

In the realm of legal and medical investigations, the decision to conduct a private autopsy can be crucial.

Navigating menopause can be challenging, but finding natural solutions can make a significant difference.

IVIEW Therapeutics Inc., a clinical stage biotechnology company advancing innovative treatments for ocular diseases, proudly announces the dosing of the first patient in the Phase 1/2 clinical trial of IVW-1001 Ophthalmic Eyelid Wipe.

The Ripple Effect Healing Arts is a wellness company that has recently gained attention for their use of Wild Yam Cream, located in Bourbonnais, Illinois.

CPC announces the completion of a rigorous four-day audit conducted by Australia's Therapeutic Goods Administration (TGA), the country's government authority responsible for evaluating, assessing, and monitoring approved products defined as therapeutic...

Company sees continued strong growth of its customer base across the board

Neurolixis issued a new US patent for treatment of Fragile X syndrome with NLX-101

Onconostic Technologies-3N Diagnostics Group (OT/3NDx), a leader in precision oncology diagnostics, today announced study results from the Phase III GEICAM/CIBOMA clinical trial involving patients diagnosed with triple-negative breast cancer (TNBC).

Bronchoscopy is known to be an aerosol generating procedure and produce plumes of microscopic particles, some of which may carry infectious airborne organisms, that can then be inhaled by medical personnel in attendance and subsequently pose a high-risk..

Quantoom Biosciences and Tiamat Sciences Announce Strategic Partnership to Revolutionize mRNA Production Quantoom Biosciences S.A.

Provenance Bio, an alternative protein company, announced today that its hydroxylated type I collagen protein demonstrates proof of function by matching the cell adhesion strength of fibronectin, providing promising scalable and sustainable protein...

OncoBeta® GmbH, a global medical device company specialising in innovative therapies for non-melanoma skin cancers (NMSCs), is supporting World Skin Cancer Awareness Month (May 2024) by focusing on educating patients suffering with NMSCs about the...

OncoBeta® GmbH, a global medical device company specialising in innovative therapies for non-melanoma skin cancers (NMSCs), is supporting World Skin Cancer Awareness Month (May 2024) by focusing on educating patients suffering with NMSCs about the...

OncoBeta® GmbH, a global medical device company specialising in innovative therapies for non-melanoma skin cancers (NMSCs), is supporting World Skin Cancer Awareness Month (May 2024) by focusing on educating patients suffering with NMSCs about the...

OncoBeta® GmbH, a global medical device company specialising in innovative therapies for non-melanoma skin cancers (NMSCs), is supporting World Skin Cancer Awareness Month (May 2024) by focusing on educating patients suffering with NMSCs about the...

Software Development Firm Introduces Groundbreaking App to Facilitate Seamless Transfer of Patient Records for former Smile Direct Club Patrons

Neuroprotective Efficacy of the Glucocorticoid Receptor Modulator PT150 in the Rotenone Mouse Model of Parkinson's Disease

Kytura Naturals, a new premium organic oil company, officially launches today in Calgary, Alberta. Founded by Dr.

Exclusive: How a small group of patient advocates and biotech companies tricked the Utah legislature into passing a law which sets a precedent. Utah is now the first state to legalize therapy with stem cells from placenta tissue and cord blood.

Manhattan BioSolutions, Inc. ("Manhattan Bio"), an emerging biotechnology company developing new classes of precision biologics for the treatment of advanced cancers, today announced a collaborative poster presentation at the American Association for...

In the realm of legal and medical investigations, the decision to conduct a private autopsy can be crucial.

Abstract: Chemical resistance is a critical factor in the selection of materials for various industrial and laboratory applications.

Navigating menopause can be challenging, but finding natural solutions can make a significant difference.

IVIEW Therapeutics Inc., a clinical stage biotechnology company advancing innovative treatments for ocular diseases, proudly announces the dosing of the first patient in the Phase 1/2 clinical trial of IVW-1001 Ophthalmic Eyelid Wipe.

Daicel Arbor Biosciences is excited to announce the release of the next generation of its myTXTL® kits, for cell-free protein expression, designed to simplify and accelerate antibody discovery and protein engineering.

Manhattan BioSolutions, Inc. (MABS), an emerging biotech company developing new classes of precision biologics for the treatment of advanced cancers, and the Institute of Chemical Biology & Drug Discovery (ICB&DD) at Stony Brook University, led...

Discover the rapid growth of the global genotyping assay market, projected to reach USD 76,560 million by 2030. Explore key drivers, leading companies, and diverse applications in personalized medicine, diagnostics, agriculture, and more.

Ace Therapeutics, a leading provider of preclinical research services, is pleased to announce that it offers clients a comprehensive range of services for preclinical in vivo studies focused on glaucoma research.

The Ripple Effect Healing Arts is a wellness company that has recently gained attention for their use of Wild Yam Cream, located in Bourbonnais, Illinois.

Sellomics and provitro announce an Interactive TMA Workshop for Target ID/Validation and Biomarkers. Designed for professionals in oncology, pathology, and drug development, gain insights into the latest TMA advancements and techniques.

Ace Therapeutics is proud to announce the launch of its extensive suite of diabetic mouse models.

CPC announces the completion of a rigorous four-day audit conducted by Australia's Therapeutic Goods Administration (TGA), the country's government authority responsible for evaluating, assessing, and monitoring approved products defined as therapeutic...

Nova Biomedical today announced the availability of the Nova Primary™ glucose reference analyzer, filling the need left by the discontinued YSI 2300 STAT PLUS Glucose and L-Lactate analyzer (YSI, Inc., Yellow Springs, OH).

Onconostic Technologies-3N Diagnostics Group (OT/3NDx), an emerging leader in precision oncology diagnostics, today announced clinical validation of the pan-cancer, tissue agnostic utility of VERESCA based on detection of FOXC1 protein in oral cancer.

TSA Process Equipments is thrilled to announce its participation in ACHEMA 2024, one of the world's leading trade fairs of successful and innovative companies in the process industries, taking place in Frankfurt, Germany, from June 10-14, 2024.

Company sees continued strong growth of its customer base across the board

Are you looking to find the right diet for your body? Are you tired of the innumerable diet advice available online? Then iVate Ayurveda is the best solution for you.

Neurolixis issued a new US patent for treatment of Fragile X syndrome with NLX-101

Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to announce its partnership with the Experimental Drug Development Centre (EDDC), Singapore's national platform for drug discovery and development hosted by the.

Everfront Biotech is set to participate in the North American Biotechnology Exhibition (BIO 2024), held in San Diego, USA, from June 3 to June 6, 2024.

Onconostic Technologies-3N Diagnostics Group (OT/3NDx), a leader in precision oncology diagnostics, today announced study results from the Phase III GEICAM/CIBOMA clinical trial involving patients diagnosed with triple-negative breast cancer (TNBC).

Bronchoscopy is known to be an aerosol generating procedure and produce plumes of microscopic particles, some of which may carry infectious airborne organisms, that can then be inhaled by medical personnel in attendance and subsequently pose a high-risk..

Potrzebujesz nowego wytrząsarki do swojego laboratorium i nie wiesz od czego zacząć? Przy wyborze wytrząsarki należy wziąć pod uwagę wiele czynników, a firma OHAUS pomoże Ci znaleźć odpowiedni model.

Ace Therapeutics, an integrated research service company offering a wide range of parasitology solutions, services, and products, announced the expansion of its parasitology research capabilities with the introduction of its new parasite testing...

Quantoom Biosciences and Tiamat Sciences Announce Strategic Partnership to Revolutionize mRNA Production Quantoom Biosciences S.A.

ARJUNA Therapeutics is pleased to announce the award of a prize from the MATWIN International Board at the 2024 MATWIN Congress in Bordeaux, France.

Provenance Bio, an alternative protein company, announced today that its hydroxylated type I collagen protein demonstrates proof of function by matching the cell adhesion strength of fibronectin, providing promising scalable and sustainable protein...

OncoBeta® GmbH, a global medical device company specialising in innovative therapies for non-melanoma skin cancers (NMSCs), is supporting World Skin Cancer Awareness Month (May 2024) by focusing on educating patients suffering with NMSCs about the...

OncoBeta® GmbH, a global medical device company specialising in innovative therapies for non-melanoma skin cancers (NMSCs), is supporting World Skin Cancer Awareness Month (May 2024) by focusing on educating patients suffering with NMSCs about the...

OncoBeta® GmbH, a global medical device company specialising in innovative therapies for non-melanoma skin cancers (NMSCs), is supporting World Skin Cancer Awareness Month (May 2024) by focusing on educating patients suffering with NMSCs about the...

OncoBeta® GmbH, a global medical device company specialising in innovative therapies for non-melanoma skin cancers (NMSCs), is supporting World Skin Cancer Awareness Month (May 2024) by focusing on educating patients suffering with NMSCs about the...